Goeree R - Search Results

1

The value and consequences of using public health technology assessments for private payer decision-making in Canada: one size does not fit all.

Pericleous L, Amin M, Goeree R. Pericleous L, et al. Among authors: goeree r. J Med Econ. 2019 May;22(5):478-487. doi: 10.1080/13696998.2019.1582535. Epub 2019 Mar 4. J Med Econ. 2019. PMID: 30757934 Free article.

2

Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada From 2002 to 2018.

Mackinnon ES, Goeree R, Goodman SG, Rogoza RM, Packalen M, Pericleous L, Motsepe-Ditshego P, Oh P. Mackinnon ES, et al. Among authors: goeree r. CJC Open. 2021 Oct 20;4(2):206-213. doi: 10.1016/j.cjco.2021.10.003. eCollection 2022 Feb. CJC Open. 2021. PMID: 35198938 Free PMC article.

3

Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.

Xie F, Bowen JM, Sutherland SC, Burke N, Blackhouse G, Tarride JE, O'Reilly D, Goeree R. Xie F, et al. Among authors: goeree r. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):513-21. doi: 10.1586/erp.11.60. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21958096

4

Evidence-Based Decision Making 3: Health Technology Assessment.

O'Reilly D, Audas R, Campbell K, Vanstone M, Bowen JM, Schwartz L, Assasi N, Goeree R. O'Reilly D, et al. Among authors: goeree r. Methods Mol Biol. 2021;2249:429-454. doi: 10.1007/978-1-0716-1138-8_23. Methods Mol Biol. 2021. PMID: 33871857

5

Basics of health technology assessment.

O'Reilly D, Campbell K, Goeree R; Programs for Assessment of Technology in Health Research Institute. O'Reilly D, et al. Among authors: goeree r. Methods Mol Biol. 2009;473:263-83. doi: 10.1007/978-1-59745-385-1_16. Methods Mol Biol. 2009. PMID: 19160744 Review.

6

Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada.

Moshyk A, Martel MJ, Tahami Monfared AA, Goeree R. Moshyk A, et al. Among authors: goeree r. J Med Econ. 2016;19(2):181-92. doi: 10.3111/13696998.2015.1106546. Epub 2015 Nov 11. J Med Econ. 2016. PMID: 26453248 Free article.

7

Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada.

Goeree R, Goeree J. Goeree R, et al. Among authors: goeree j. J Med Econ. 2016;19(3):277-91. doi: 10.3111/13696998.2015.1116992. Epub 2015 Nov 30. J Med Econ. 2016. PMID: 26535790 Free article.

8

Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada.

Chau D, Becker DL, Coombes ME, Ioannidis G, Adachi JD, Goeree R. Chau D, et al. Among authors: goeree r. J Med Econ. 2012;15 Suppl 1:3-14. doi: 10.3111/13696998.2012.737393. Epub 2012 Oct 16. J Med Econ. 2012. PMID: 23035625 Free article.

9

Evidence-based decision-making 3: Health technology assessment.

O'Reilly D, Campbell K, Vanstone M, Bowen JM, Schwartz L, Assasi N, Goeree R. O'Reilly D, et al. Among authors: goeree r. Methods Mol Biol. 2015;1281:417-41. doi: 10.1007/978-1-4939-2428-8_25. Methods Mol Biol. 2015. PMID: 25694325

10

Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessments.

McCarron CE, Pullenayegum EM, Marshall DA, Goeree R, Tarride JE. McCarron CE, et al. Among authors: goeree r. Int J Technol Assess Health Care. 2009 Oct;25(4):546-54. doi: 10.1017/S0266462309990316. Int J Technol Assess Health Care. 2009. PMID: 19845985 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters